.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have introduced a promising approach for liver fibrosis treatment using a novel nanotechnology platform. However, liver fibrosis acts as a dangerous precursor to cirrhosis in patients with chronic liver diseases. Consequently, current clinical options often fail due to systemic side effects or low tissue specificity. Therefore, to overcome these barriers, scientists developed the Lac-AGly nanoparticle system. This platform utilizes natural glycogen as a biodegradable backbone. Notably, researchers modified the glycogen with lactobionic acid to target asialoglycoprotein receptors (ASGPR) on hepatocytes. For instance, this modification ensures that the therapeutic payload reaches the intended site with high precision.
This system delivers small interfering RNA (siRNA) specifically designed to silence connective tissue growth factor (CTGF). Furthermore, the researchers achieved a 51.2% degree of amination on the glycogen backbone. This modification conferred efficient siRNA binding capacity. Specifically, the resulting nanocomplexes maintained a uniform spherical shape and an average particle size of 247.2 nm. Moreover, in vivo testing revealed remarkable results in animal models. In addition, the treatment reduced the collagen-positive area in the liver from 14.3% to just 3.1%. Consequently, this platform demonstrates significant potential for clinical translation. Overall, it offers a safe and effective way to achieve gene-silencing without harming healthy tissues.
The system uses lactobionic acid to recognize asialoglycoprotein receptors (ASGPR). These receptors are primarily expressed on the surface of hepatocytes. Therefore, the siRNA is delivered directly to the liver cells.
Connective tissue growth factor (CTGF) is a key protein that promotes the accumulation of collagen and scar tissue. Specifically, silencing this gene helps halt and reverse the fibrotic process.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers developed a glycogen-based nanoparticle platform that targets hepatocytes to silence CTGF, significantly reducing liver fibrosis in vivo....
5 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
